Alnylam and Cubist Form Strategic Collaboration to Develop and ... - Genetic Engineering News

by Hgh @ Wed, 14 Jan 2009 03:00:08 -0500
Cubist Pharmaceuticals, Inc., ( Nasdaq: CBST ), a leading acute care biopharmaceutical company, and Alnylam Pharmaceuticals, Inc. ( Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that they have formed a strategic collaboration to ...
  • Recent posts: